Schrodinger Current Ratio 2019-2025 | SDGR
Schrodinger current ratio from 2019 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Schrodinger Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $0.51B | $0.16B | 3.30 |
| 2025-03-31 | $0.57B | $0.17B | 3.45 |
| 2024-12-31 | $0.64B | $0.19B | 3.31 |
| 2024-09-30 | $0.46B | $0.11B | 4.11 |
| 2024-06-30 | $0.45B | $0.10B | 4.50 |
| 2024-03-31 | $0.49B | $0.11B | 4.64 |
| 2023-12-31 | $0.57B | $0.13B | 4.25 |
| 2023-09-30 | $0.55B | $0.11B | 5.22 |
| 2023-06-30 | $0.59B | $0.11B | 5.54 |
| 2023-03-31 | $0.60B | $0.12B | 4.89 |
| 2022-12-31 | $0.53B | $0.11B | 4.91 |
| 2022-09-30 | $0.52B | $0.09B | 5.90 |
| 2022-06-30 | $0.56B | $0.09B | 6.51 |
| 2022-03-31 | $0.59B | $0.09B | 6.85 |
| 2021-12-31 | $0.63B | $0.09B | 6.85 |
| 2021-09-30 | $0.62B | $0.07B | 8.53 |
| 2021-06-30 | $0.65B | $0.07B | 9.23 |
| 2021-03-31 | $0.68B | $0.07B | 9.99 |
| 2020-12-31 | $0.68B | $0.07B | 9.33 |
| 2020-09-30 | $0.62B | $0.04B | 15.81 |
| 2020-06-30 | $0.31B | $0.04B | 7.13 |
| 2020-03-31 | $0.31B | $0.04B | 7.42 |
| 2019-12-31 | $0.12B | $0.05B | 2.63 |
| 2019-09-30 | $0.00B | 0.00 | |
| 2019-06-30 | $0.00B | 0.00 | |
| 2019-03-31 | $0.00B | 0.00 | |
| 2018-12-31 | $0.11B | $0.03B | 3.88 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.346B | $0.208B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $48.476B | 59.15 |
| Tempus AI (TEM) | United States | $12.470B | 0.00 |
| Doximity (DOCS) | United States | $9.841B | 40.73 |
| Hims & Hers Health (HIMS) | United States | $9.345B | 76.02 |
| IRhythm Technologies (IRTC) | United States | $5.680B | 0.00 |
| Hinge Health (HNGE) | United States | $3.475B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Heartflow (HTFL) | United States | $2.821B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.501B | 41.38 |
| 10x Genomics (TXG) | United States | $2.126B | 0.00 |
| Enovis (ENOV) | United States | $1.731B | 9.09 |
| Omnicell (OMCL) | United States | $1.652B | 33.77 |
| Azenta (AZTA) | United States | $1.387B | 60.52 |
| Phreesia (PHR) | United States | $1.355B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.333B | 0.00 |
| Claritev (CTEV) | United States | $0.953B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.840B | 0.00 |
| Evolent Health (EVH) | United States | $0.582B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.561B | 0.00 |
| Talkspace (TALK) | United States | $0.560B | 112.67 |
| Veradigm (MDRX) | United States | $0.517B | 0.00 |
| Standard BioTools (LAB) | United States | $0.450B | 0.00 |
| Carlsmed (CARL) | United States | $0.335B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.325B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.294B | 0.00 |
| TruBridge (TBRG) | United States | $0.286B | 13.15 |
| CapsoVision (CV) | United States | $0.231B | 0.00 |
| Outset Medical (OM) | United States | $0.214B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.210B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.201B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.195B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.183B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.181B | 0.00 |
| CareCloud (CCLD) | United States | $0.143B | 7.84 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Pulmonx (LUNG) | United States | $0.079B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.075B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.054B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.040B | 0.00 |
| 111 (YI) | China | $0.036B | 0.00 |
| Precipio (PRPO) | United States | $0.033B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.025B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.021B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.000B | 0.00 |